缩写名/全名 |
DRUG DEVELOP RES
DRUG DEVELOPMENT RESEARCH |
||||||||||||||||
ISSN号 | 0272-4391 | ||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||
影响因子 | 2015:0.984, 2016:1.909, 2017:2.646, 2018:1.742, 2019:1.902, | ||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||
年文章数 | 95 | ||||||||||||||||
出版年份 | 1981 | ||||||||||||||||
是否OA | No | ||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||
录用比例 | 容易 | ||||||||||||||||
投稿链接 | https://mc.manuscriptcentral.com/ddr | ||||||||||||||||
投稿官网 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2299 | ||||||||||||||||
h-index | 54 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0272-4391%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats. Author: Jin X1, Zhao T2, Shi D3, Ye MB4, Yi Q5. Journal: Drug Dev Res. 2019 Mar;80(2):209-217. doi: 10.1002/ddr.21451. Epub 2018 Oct 31. PubMed DOI |
2. | Preparation, optimization, and pharmacokinetic study of nanoliposomes loaded with triacylglycerol-bound punicic acid for increased antihepatotoxic activity. Author: Adu-Frimpong M1,2, Firempong CK3, Omari-Siaw E4, Wang Q1, Mukhtar YM1, Deng W1, Yu Q1, Xu X1, Yu J1. Journal: Drug Dev Res. 2019 Mar;80(2):230-245. doi: 10.1002/ddr.21485. Epub 2018 Nov 10. PubMed DOI |
3. | Drug sales confirm clinical advantage of multi-target inhibition of drug escapes by anticancer kinase inhibitors. Author: Chen S1, Yang SY2, Chen Z3, Tan Y1, Jiang YY1, Chen YZ4. Journal: Drug Dev Res. 2019 Mar;80(2):246-252. doi: 10.1002/ddr.21486. Epub 2018 Nov 13. PubMed DOI |
4. | Effect of Syringic acid on antioxidant biomarkers and associated inflammatory markers in mice model of asthma. Author: Li Y1,2, Zhang L2, Wang X2, Wu W3, Qin R1. Journal: Drug Dev Res. 2019 Mar;80(2):253-261. doi: 10.1002/ddr.21487. Epub 2018 Nov 25. PubMed DOI |
5. | Mechanism of penehyclidine hydrochloride on a dysmenorrhea rat model. Author: Xiao H1,2,3, Shi T1,3, Han L1,3, Tong R1,3, Liao Z4. Journal: Drug Dev Res. 2019 May;80(3):325-332. doi: 10.1002/ddr.21500. Epub 2018 Dec 3. PubMed DOI |
6. | Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging. Author: Li Y1, Sun F1, Zhang W1,2. Journal: Drug Dev Res. 2019 Feb;80(1):98-105. doi: 10.1002/ddr.21498. Epub 2018 Dec 11. PubMed DOI |
7. | Protective effects of quercetin against inflammation and oxidative stress in a rabbit model of knee osteoarthritis. Author: Wei B1, Zhang Y2, Tang L3, Ji Y1, Yan C1, Zhang X1. Journal: Drug Dev Res. 2019 May;80(3):360-367. doi: 10.1002/ddr.21510. Epub 2019 Jan 4. PubMed DOI |
8. | Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4 /MyD88/NF-κB signal pathway. Author: Zhang Y1, Zeng Y2. Journal: Drug Dev Res. 2019 May;80(3):353-359. doi: 10.1002/ddr.21509. Epub 2019 Jan 21. PubMed DOI |
9. | Structure-activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition. Author: Gao XH1, Tang JJ2, Liu HR2, Liu LB2, Liu YZ3. Journal: Drug Dev Res. 2019 Jan 24. doi: 10.1002/ddr.21515. [Epub ahead of print] PubMed DOI |
10. | Mechanisms underlying isoliquiritigenin-induced apoptosis and cell cycle arrest via ROS-mediated MAPK/STAT3/NF-κB pathways in human hepatocellular carcinoma cells. Author: Wang JR1, Luo YH2, Piao XJ3, Zhang Y1, Feng YC4, Li JQ1, Xu WT1, Zhang Y1, Zhang T1, Wang SN1, Xue H1, Wang WZ1, Cao LK4, Jin CH1,4. Journal: Drug Dev Res. 2019 Jan 30. doi: 10.1002/ddr.21518. [Epub ahead of print] PubMed DOI |
|
|